CAC
GNRSW

Cowen and Company’s Greenrose Acquisition Corp. Warrant GNRSW Stock Holding History

Cowen and Company’s Portfolio GNRSW Stock Details GNRSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$17K – 858
2021
Q1 		$17K Sell
20,000
-5,000
-20% -$6.97K ﹤0.01% 464
2020
Q4 		$25K Sell
25,000
-63,059
-72% -$30.5K ﹤0.01% 314
2020
Q3 		$21K Sell
88,059
-203,840
-70% -$50.3K ﹤0.01% 354
2020
Q2 		$61K Buy
+291,899
New +$74K 0.01% 275

Other funds holding GNRSW

TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return

Cowen and Company's GNRSW Position: Q2 2021 in Review

Cowen and Company sold out of Greenrose Acquisition Corp. Warrant (GNRSW) in Q2 2021, closing a stake of 20,000 shares — an estimated $17K sold.

Cowen and Company first reported a position in GNRSW in Q2 2020 and held it in 4 quarters. The position peaked at $61K in Q2 2020. 7 funds tracked by Wall St. Rank hold GNRSW as of Q2 2021.

  • Cowen and Company reported no remaining Greenrose Acquisition Corp. Warrant position as of Q2 2021 after selling out during the quarter.
  • Cowen and Company sold 20,000 Greenrose Acquisition Corp. Warrant shares in Q2 2021, an estimated $17K.
  • Cowen and Company first reported a position in Greenrose Acquisition Corp. Warrant in Q2 2020 and held it in 4 quarters.
  • Cowen and Company's Greenrose Acquisition Corp. Warrant position peaked at $61K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Greenrose Acquisition Corp. Warrant as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.